Showing results (631-640 of 5,712) with videos related to
Sort By:
Pageof 572
Medical Oncology (Northwood, London, England)|March 25, 2009
Altered iron metabolism, inflammation, transferrin receptors, and ferritin expression in non-small-cell lung cancerSuzana Kukulj, Morana Jaganjac, Milivoj Boranic, et al.Medical Oncology (Northwood, London, England)|March 25, 2009
Risk stratification for recurrence in patients with esophageal and junctional carcinoma treated with neoadjuvant chemotherapy and surgeryS Dixit, M Tilston, W M PeterMedical Oncology (Northwood, London, England)|February 14, 2009
Survival and prognostic factors in small cell lung cancerJian Li, Chun-Hua Dai, Ping Chen, et al.Medical Oncology (Northwood, London, England)|March 26, 2009
CHOP-21 for unfavorable Hodgkin's lymphoma. An exploratory studyJan Walewski, Elzbieta Lampka, Joanna Tajer, et al.Medical Oncology (Northwood, London, England)|December 6, 2013
Elevated expression patterns and tight correlation of the PLCE1 and NF-κB signaling in Kazakh patients with esophageal carcinomaXiao-Bin Cui, Xue-Lian Pang, Su Li, et al.Medical Oncology (Northwood, London, England)|December 6, 2013
Expression level of phosphorylated-4E-binding protein 1 in radical nephrectomy specimens as a prognostic predictor in patients with metastatic renal cell carcinoma treated with mammalian target of rapamycin inhibitorsMasatomo Nishikawa, Hideaki Miyake, Ken-Ichi Harada, et al.Medical Oncology (Northwood, London, England)|December 10, 2013
MiR-139 targets CXCR4 and inhibits the proliferation and metastasis of laryngeal squamous carcinoma cellsHua-Nan Luo, Zheng-Hui Wang, Ying Sheng, et al.Medical Oncology (Northwood, London, England)|December 11, 2013
Normoxic or hypoxic CD44/CD41 a₂ B₁ integrin-positive prostate PC3 cell side fractions and cancer stem cellsK M Anderson, P Guinan, M RubensteinMedical Oncology (Northwood, London, England)|October 10, 2013
Decreased Kruppel-like factor 4 (KLF4) expression may correlate with poor survival in gastric adenocarcinomaLi-Sung Hsu, Chien-Pin Chan, Chih-Jung Chen, et al.Medical Oncology (Northwood, London, England)|October 15, 2013
S-1 plus CIK as second-line treatment for advanced pancreatic cancerMeng Wang, Sheng-bin Shi, Jie-lin Qi, et al.Pageof 572